JP2024102139A5 - - Google Patents

Download PDF

Info

Publication number
JP2024102139A5
JP2024102139A5 JP2024070307A JP2024070307A JP2024102139A5 JP 2024102139 A5 JP2024102139 A5 JP 2024102139A5 JP 2024070307 A JP2024070307 A JP 2024070307A JP 2024070307 A JP2024070307 A JP 2024070307A JP 2024102139 A5 JP2024102139 A5 JP 2024102139A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cav3 antagonist
release component
plasma concentration
cav3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024070307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024102139A (ja
JP7855629B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2019/054498 external-priority patent/WO2020072773A1/en
Application filed filed Critical
Publication of JP2024102139A publication Critical patent/JP2024102139A/ja
Publication of JP2024102139A5 publication Critical patent/JP2024102139A5/ja
Application granted granted Critical
Publication of JP7855629B2 publication Critical patent/JP7855629B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024070307A 2018-10-03 2024-04-24 （ｒ）－２－（４－イソプロピルフェニル）－ｎ－（１－（５－（２，２，２－トリフルオロエトキシ）ピリジン－２－イル）エチル）アセトアミドを使用した本態性振戦の処置 Active JP7855629B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862740755P 2018-10-03 2018-10-03
US62/740,755 2018-10-03
US201862780049P 2018-12-14 2018-12-14
US62/780,049 2018-12-14
PCT/US2019/054498 WO2020072773A1 (en) 2018-10-03 2019-10-03 Treating essential tremor using (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide
JP2021518473A JP7480131B2 (ja) 2018-10-03 2019-10-03 （ｒ）－２－（４－イソプロピルフェニル）－ｎ－（１－（５－（２，２，２－トリフルオロエトキシ）ピリジン－２－イル）エチル）アセトアミドを使用した本態性振戦の処置

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021518473A Division JP7480131B2 (ja) 2018-10-03 2019-10-03 （ｒ）－２－（４－イソプロピルフェニル）－ｎ－（１－（５－（２，２，２－トリフルオロエトキシ）ピリジン－２－イル）エチル）アセトアミドを使用した本態性振戦の処置

Publications (3)

Publication Number Publication Date
JP2024102139A JP2024102139A (ja) 2024-07-30
JP2024102139A5 true JP2024102139A5 (https=) 2025-01-27
JP7855629B2 JP7855629B2 (ja) 2026-05-08

Family

ID=

Similar Documents

Publication Publication Date Title
JP4846063B2 (ja) 選択的ｓ１ｐ１レセプターアゴニストの投与法
EP2167099B1 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
JP2019218389A (ja) 代謝障害を治療するための組成物および方法
TW200412934A (en) Pharmaceutical formulations of modafinil
JP2505944B2 (ja) （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物
US20110172210A1 (en) Method for titrating clozapine
KR20140121491A (ko) 체중 감량을 성취하고 비만을 치료하기 위한 단계적상승 투여 요법
CN107205950B (zh) 金刚烷胺组合物的施用方法
BR112020008128A2 (pt) comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos
JP2015517994A (ja) ハロフジノンの剤形およびその使用
JP2016074728A (ja) 脱髄性および他の神経系疾患を患っている患者における神経認知的および／または神経精神医学的障害を改善するための４−アミノピリジンの使用
JP3168543B2 (ja) バスピロン：睡眠誘起性無呼吸症剤
JP2024102139A5 (https=)
WO1996011682A1 (en) Preventive and remedy for type i allergic diseases
BG64614B1 (bg) Използване на прамипексол при лечение на синдрома на неспокойни крака
WO2020183020A1 (en) Capsid assembly modulator solid formulation
JP3227578B2 (ja) 睡眠誘起性無呼吸症治療剤
EP1503746B1 (en) Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
KR20160025075A (ko) 구강내 속붕해 필름 조성물 및 그 제조방법
JP6420923B1 (ja) 医薬
RU2837048C1 (ru) Долгосрочный реабсорбируемый подкожный имплантат с устойчивым высвобождением предварительно концентрированного фармакологически активного вещества в полимере для лечения болезни паркинсона
WO2025194118A1 (en) Formulations and methods for alleviating sleep disorders
TWI461192B (zh) 降低血脂異常病患之糖化血色素的醫藥組成物
AU2014213552B2 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
JP2024541770A5 (https=)